Not true. The folfirinox chemo regimen was invented a couple of years ago, and it significantly increased the life expectancy and quality of life for terminal pancreatic cancer patients.[0]
Cancer is a problem that can be solved, and it needs to be solved asap. Cancer too often gets either relegated to "Actually, statistically it's very unlikely" by people who don't have it or stylized to the God of Death that unlike other illness we won't solve anytime soon. There is no time to be lost tackling with AI. Dario gets it. Had cancer himself and his father passed away from it.
Unless we can reliably sign our cells like we do our binaries, we ain't "solving" cancer.
Am I missing something?
From other sources:
> Median overall survival: 13.2 months versus about 6.6 to 6.7 months with chemotherapy.
Merely counting months does not do much - you'd have to count the quality of these months too.
I don't see that as a breakthrough.
> Treatment-related adverse events that led to treatment discontinuation occurred in 1.2% of the patients in the daraxonrasib group and in 11.2% of those in the chemotherapy group.
That's a huge reduction in side effects bad enough to stop treatment.